Formed at the start of the pandemic in March 2020, the COVID-19 Genomics UK (COG-UK) consortium contributed to the UK’s COVID-19 response through genome sequencing. As a research consortium, COG-UK has focused on providing genome data that informs public health actions and supports policy decisions.
Moreover, through the tireless sequencing efforts across the COG-UK network in the last 16 months, our unique dataset will help us to explore a deeper understanding of why some people develop severe disease – through the combined analysis of viral and human genomes and detailed patient information. Our ambition is that this will lead to improvements in patient care.
Having developed a world-class sequencing network with its associated methods and analysis tools, COG-UK has now initiated the handover of routine sequencing to a national sequencing service run by the four UK public health authorities to provide a sustainable, long-term framework.
Here, we depict our transition journey and celebrate the lasting legacy of COG-UK sequencing efforts.